Get started
Boundless Bio, Inc.Boundless Bio, Inc.Boundless Bio, Inc.

Boundless Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BOLD chart


Full chart

BOLD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪57.53 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.75 USD
Net income (FY)
‪−49.43 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪14.17 M‬
Beta (1Y)
3.17

Employees


Employees (FY)
72
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−686.58 K‬ USD

About Boundless Bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Zachary D. Hornby
Website
boundlessbio.com
Headquarters
San Diego
Founded
2018
FIGI
BBG00Q4W34T4
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BOLD news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BOLD is 2.58 USD — it has increased by 0.78% in the past 24 hours. Watch Boundless Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Boundless Bio, Inc. stocks are traded under the ticker BOLD.
BOLD stock has risen by 2.38% compared to the previous week, the month change is a −1.34% fall, over the last year Boundless Bio, Inc. has showed a −81.89% decrease.
We've gathered analysts' opinions on Boundless Bio, Inc. future price: according to them, BOLD price has a max estimate of 20.00 USD and a min estimate of 14.00 USD. Watch BOLD chart and read a more detailed Boundless Bio, Inc. stock forecast: see what analysts think of Boundless Bio, Inc. and suggest that you do with its stocks.
BOLD reached its all-time high on Mar 28, 2024 with the price of 15.24 USD, and its all-time low was 2.33 USD and was reached on Nov 22, 2024. View more price dynamics on BOLD chart.
See other stocks reaching their highest and lowest prices.
BOLD stock is 10.11% volatile and has beta coefficient of 3.17. Track Boundless Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Boundless Bio, Inc. there?
Today Boundless Bio, Inc. has the market capitalization of ‪57.53 M‬, it has increased by 1.19% over the last week.
Yes, you can track Boundless Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Boundless Bio, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
BOLD earnings for the last quarter are −0.74 USD per share, whereas the estimation was −0.75 USD resulting in a 1.00% surprise. The estimated earnings for the next quarter are −0.76 USD per share. See more details about Boundless Bio, Inc. earnings.
Boundless Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BOLD net income for the last quarter is ‪−16.51 M‬ USD, while the quarter before that showed ‪−16.98 M‬ USD of net income which accounts for 2.75% change. Track more Boundless Bio, Inc. financial stats to get the full picture.
No, BOLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 72.00 employees. See our rating of the largest employees — is Boundless Bio, Inc. on this list?
Like other stocks, BOLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boundless Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Boundless Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Boundless Bio, Inc. stock shows the strong sell signal. See more of Boundless Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.